Compugen, DiagnoCure Win $800K Grant to Develop Lung-Cancer Diagnostic | GenomeWeb

NEW YORK, March 13 - Compugen and biotech company DiagnoCure have won an $800,000 grant from the Canada-Israel Industrial Research and Development Foundation to create a nucleic-acid probe-based diagnostic for lung cancer.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.